You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List.
by Thermo Fisher Scientific
Panel discussion highlights the benefits of keeping it close
Precision medicine is key to every aspect of modern oncology – and comprehensive genomic profiling can help
Results from early access trials demonstrate the reproducibility and reliability of a pan-cancer next-generation sequencing assay
A tumor gene test has been developed that may predict poor survival in patients with ovarian cancer
To improve immunotherapy outcomes, we need to explore new biomarkers that offer spatial resolution in the tumor microenvironment
As the UK heads toward test centralization, medical oncologist Tanya Ahmad explains why in-house testing shouldn’t be left behind
We sit down with HRH Princess Dina Mired to find out what brought her to cancer advocacy and how she sees future cancer care in the developing world
A new computational tool may help identify cancer driver mutations in noncoding regions of the genome
What ctDNA and CTCs can tell us about the likelihood of breast cancer survival and recurrence
Establishing an accurate, understandable classification system for conjunctival epithelial pigmentations
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.